Network Medicine Strikes a Blow against Breast Cancer

Janine Terra Erler, Rune Linding

    Research output: Contribution to journalJournal articleResearchpeer-review


    Drug development for complex diseases is shifting from targeting individual proteins or genes to systems-based attacks targeting dynamic network states. Lee et al. now reveal how the progressive rewiring of a signaling network over time following EGF receptor inhibition leaves triple-negative breast tumors vulnerable to a second, later hit with DNA-damaging drugs, demonstrating that time- and order-dependent drug combinations can be more efficacious in killing cancer cells.
    Original languageEnglish
    Issue number4
    Pages (from-to)731-733
    Publication statusPublished - 2012


    Dive into the research topics of 'Network Medicine Strikes a Blow against Breast Cancer'. Together they form a unique fingerprint.

    Cite this